Allergan Plc (AGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2020 | 12-2019 | 09-2019 | 06-2019 | 03-2019 | |
| Sales | 3,604,400 | 4,351,000 | 4,050,700 | 4,090,100 | 3,597,100 |
| Cost of Goods | 623,100 | 704,000 | 639,000 | 652,300 | 497,800 |
| Gross Profit | 2,981,300 | 3,647,001 | 3,411,700 | 3,437,800 | 3,099,300 |
| Operating Expenses | 4,281,000 | 3,923,600 | 4,008,300 | 4,701,000 | 5,409,300 |
| Operating Income | -1,299,600 | -276,600 | -596,600 | -1,262,900 | -2,309,200 |
| Interest Expense | 184,500 | 191,900 | 193,900 | 195,400 | 201,800 |
| Other Income | -3,700 | 46,500 | 23,000 | 5,000 | 35,100 |
| Pre-tax Income | -1,487,800 | -422,000 | -767,500 | -1,453,300 | -2,475,900 |
| Income Tax | -1,866,800 | -104,700 | 18,100 | 301,600 | -68,600 |
| Net Income Continuous | 379,000 | -317,300 | -785,600 | -1,754,900 | -2,407,300 |
| Minority Interests | 1,000 | -100 | 1,200 | 4,100 | 700 |
| Net Income | $378,000 | $-317,200 | $-786,800 | $-1,759,000 | $-2,408,000 |
| EPS Basic Total Ops | 1.15 | -1.00 | -2.40 | -5.37 | -7.25 |
| EPS Basic Continuous Ops | 1.15 | -1.02 | -2.40 | -5.35 | -7.25 |
| EPS Diluted Total Ops | 1.14 | -1.00 | -2.40 | -5.37 | -7.25 |
| EPS Diluted Continuous Ops | 1.14 | -1.02 | -2.40 | -5.35 | -7.25 |
| EPS Diluted Before Non-Recurring Items | N/A | 5.22 | 4.25 | 4.38 | 3.79 |
| EBITDA(a) | $177,700 | $1,429,900 | $999,700 | $192,300 | $-857,700 |